Hartmut Koeppen

Safety and antitumor activity of recombinant soluble Apo2 ligand

Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text

Apo2l Mrna, Medicinal Chemistry, Apo2l Treatment +13

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

Gail D. Lewis Phillips, Guangmin Li, Debra L. Dugger et al. · Cancer Research · 2008 · 1.6K citations

Drug Targeting, Breast Oncology, Disulfide Linkers +12

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer, Romain Banchereau, Habib Hamidi et al. · Cancer Cell · 2020 · 520 citations · Full text

Urology, Genitourinary Cancer, Cancer Genomics +8

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Guillermo Torre‐Amione, R. Daniel Beauchamp, Hartmut Koeppen et al. · Proceedings of the National Academy of Sciences · 1990 · 405 citations · Full text

Tgf-beta-producing Tumors, Immunogenic Tumor, T-regulatory Cell +17

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes

Odile Devergne, Michael Hummel, Hartmut Koeppen et al. · Journal of Virology · 1996 · 334 citations · Full text

Inflammation, Signal Transduction, Autoimmune Disease +15